Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci

被引:0
|
作者
M. Bertin
A. Muller
X. Bertrand
C. Cornette
M. Thouverez
D. Talon
机构
[1] CHU Jean Minjoz,Service d’Hygiène Hospitalière et d’Epidémiologie Moléculaire
[2] CHU Besançon,Pharmacie Centrale
关键词
Vancomycin; Glycopeptide; Antimicrobial Resistance; Teicoplanin; Define Daily Dose;
D O I
暂无
中图分类号
学科分类号
摘要
To investigate the relationship between glycopeptide use and decreased susceptibility to teicoplanin in coagulase-negative staphylococci (CNS) isolates, data on teicoplanin susceptibility and glycopeptide use from existing microbiology laboratory and pharmacy databases were collected for the period between July 2000 and March 2001. Pooled data for the entire study period were first used to analyse associations. Univariate analysis showed that the incidence of CNS with decreased susceptibility to teicoplanin was significantly correlated with the use of glycopetides, particularly with vancomycin use. This association was confirmed by multivariate analysis. This study suggests that variations in antimicrobial resistance are related to variations in antimicrobial use in the model of CNS with decreased susceptibility to teicoplanin, thus confirming the usefulness of restricting antimicrobial prescribing as a means of controlling resistance.
引用
收藏
页码:375 / 379
页数:4
相关论文
共 50 条
  • [1] Relationship between glycopeptide use and decreased susceptibility to teicoplanin in isolates of coagulase-negative staphylococci
    Bertin, M
    Muller, A
    Bertrand, X
    Cornette, C
    Thouverez, M
    Talon, D
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2004, 23 (05) : 375 - 379
  • [2] Bacteraemia caused by coagulase-negative staphylococci exhibiting decreased susceptibility to teicoplanin
    Lallemand, S
    Thouverez, M
    Boisson, K
    Talon, D
    Bertrand, X
    [J]. JOURNAL OF HOSPITAL INFECTION, 2002, 51 (03) : 207 - 214
  • [3] Relationship Between Teicoplanin Use and Increase in Minimal Inhibitor Concentrations of Coagulase-Negative Staphylococci
    Tunccan, Ozlem Guzel
    Dizbay, Murat
    Keten, Derya Tozlu
    Ozkurt, Zubeyde Nur
    Sucak, Gulsan
    Senol, Esin
    [J]. GAZI MEDICAL JOURNAL, 2014, 25 (03): : 97 - 99
  • [4] Glycopeptide resistance in coagulase-negative staphylococci
    Biavasco, F
    Vignaroli, C
    Varaldo, PE
    [J]. EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2000, 19 (06) : 403 - 417
  • [5] Glycopeptide Resistance in Coagulase-Negative Staphylococci
    F. Biavasco
    C. Vignaroli
    P. E. Varaldo
    [J]. European Journal of Clinical Microbiology and Infectious Diseases, 2000, 19 : 403 - 417
  • [6] Decreased susceptibilities to teicoplanin and vancomycin among coagulase-negative methicillin-resistant clinical isolates of staphylococci
    Sieradzki, K
    Villari, P
    Tomasz, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (01) : 100 - 107
  • [7] TEICOPLANIN-RESISTANT COAGULASE-NEGATIVE STAPHYLOCOCCI
    ARIOLI, V
    PALLANZA, R
    [J]. LANCET, 1987, 1 (8523): : 39 - 39
  • [8] TEICOPLANIN-RESISTANT COAGULASE-NEGATIVE STAPHYLOCOCCI
    BRUMFITT, W
    HAMILTONMILLER, JMT
    NEVILLE, LO
    [J]. LANCET, 1987, 1 (8528): : 328 - 328
  • [9] ISOLATION OF COAGULASE-NEGATIVE STAPHYLOCOCCI RESISTANT TO TEICOPLANIN
    RIEGEL, P
    ELLIS, A
    JEHL, F
    [J]. PRESSE MEDICALE, 1990, 19 (22): : 1053 - 1053
  • [10] TEICOPLANIN IN THE TREATMENT OF INFECTIONS CAUSED BY COAGULASE-NEGATIVE STAPHYLOCOCCI
    HARDING, I
    GARAUD, JJ
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 21 : 93 - 103